Marché de l’administration de médicaments pharmaceutiques – Analyse des tendances et de la croissance | Année de prévision 2031

  • Report Code : TIPRE00007628
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 197
Buy Now

Le marché de la livraison de médicaments pharmaceutiques devrait atteindre 2 296 170,9 millions de dollars américains en 2027 contre 1 403 082,9 millions de dollars américains en 2019. Le marché devrait croître à un TCAC de 6,6 % au cours de la période 2020-2027 .



Les systèmes d'administration de médicaments sont les technologies principalement utilisées pour l'administration contrôlée ou ciblée de divers agents thérapeutiques pour traiter diverses maladies ou améliorer la santé des patients. Les systèmes d'administration de médicaments sont des dispositifs médicaux utilisés pour injecter des médicaments ou des produits chimiques dans le corps. Certains des systèmes d'administration de médicaments disponibles sur le marché comprennent les systèmes transmuqueux, oral, pulmonaire, injectable, topique, nasal, implantable et oculaire.



Marchés régionaux lucratifs pour l'administration de médicaments pharmaceutiques



Aperçu du marché



Prévalence croissante des maladies infectieuses et chroniques



La prévalence des maladies infectieuses, en particulier des maladies bactériennes, ne cesse d'augmenter dans le monde entier. Selon une étude publiée par l'American Society for Microbiology en 2019, le monde rapporte qu'environ 1,5 à 4,5 millions d'infections sont causées par des entérobactéries résistantes aux carbapénèmes chaque année. De plus, ce groupe de bactéries entraîne également l'hospitalisation d'environ 49 000 personnes aux États-Unis chaque année. De plus, selon une étude publiée par l'UNICEF, en 2018, la pneumonie a causé ~1 755 000 décès d'enfants âgés de <5; De plus, environ 1 200 000 enfants dans le monde ont perdu la vie à cause de la diarrhée. Cette prévalence en croissance exponentielle des maladies infectieuses entraîne la consommation de médicaments, ce qui entraîne finalement la croissance du marché de l'administration de médicaments pharmaceutiques.



Parmi les maladies chroniques, le cancer et le diabète sont la principale cause de mortalité dans le monde. Par exemple, selon une étude menée par l'American Cancer Society (ACS), les États-Unis ont signalé environ 1 735 350 nouveaux cas de cancer en 2018. De plus, selon la Fédération internationale du diabète (FID), environ 46 millions d'Américains souffraient de diabète en 2017. , et ce nombre devrait atteindre 62 millions d'ici 2045. Il a également mentionné qu'environ 425 millions de personnes dans le monde vivaient avec le diabète en 2017, et que ce nombre devrait atteindre 629 millions d'ici 2045.





Aperçus sur la voie d'administration



Le marché de l'administration de médicaments pharmaceutiques, par voie d'administration, est segmenté en administration de médicaments par voie orale, administration de médicaments injectables, administration de médicaments topiques, médicament oculaire l'administration pulmonaire, l'administration pulmonaire de médicaments, l'administration nasale de médicaments, l'administration transmuqueuse de médicaments et l'administration implantable de médicaments. Le segment de l'administration de médicaments injectables détenait la plus grande part du marché en 2019. Cependant, le segment de l'administration de médicaments topiques devrait enregistrer le TCAC le plus élevé du marché au cours de la période de prévision.



Marché de l'administration de médicaments pharmaceutiques, par Voie d'administration - 2019 et 2027



Applications Insights



Sur la base des applications, le marché de l'administration de médicaments pharmaceutiques a été segmenté en maladies infectieuses, cancer, maladies cardiovasculaires, diabète, maladies respiratoires , troubles du système nerveux central, maladies auto-immunes et autres maladies. Le segment du cancer détenait la plus grande part de marché en 2019 ; cependant, on estime que le segment des maladies infectieuses enregistre le TCAC le plus élevé au cours de la période de prévision.



Informations sur l'utilisateur final



Sur la base de l'utilisateur final, le marché de la livraison de médicaments pharmaceutiques a été segmenté dans les hôpitaux, les établissements de soins à domicile, les ASC/cliniques et d'autres utilisateurs finaux. Le segment des hôpitaux détenait la plus grande part du marché en 2019, tandis que le segment des établissements de soins à domicile devrait enregistrer le TCAC le plus élevé de 2020 à 2027.



Perspectives stratégiques



Lancements de produits et Les approbations sont une stratégie couramment adoptée par les entreprises pour étendre leur présence dans le monde et répondre à la demande croissante. Cette stratégie est le plus souvent adoptée par les acteurs du marché pour élargir leurs portefeuilles de produits correspondants.



Les acteurs opérant sur le marché de la distribution de médicaments pharmaceutiques adoptent la stratégie d'expansion pour élargir la clientèle à travers le monde ; ils mettent également en œuvre les stratégies de collaborations et de lancements de produits. Ces stratégies leur permettent de maintenir leur marque à l'échelle mondiale. Par exemple, en mai 2018, GlaxoSmithKline plc a reçu une approbation de la FDA pour l'utilisation d'Arnuity Ellipta (furoate de fluticasone) pour le traitement d'entretien de l'asthme chez les enfants de moins de 5 ans. Il s'agit d'un médicament à base de corticostéroïdes inhalés (ICS) une fois par jour.



Par voie d'administration




  • Administration de médicaments par voie orale

  • Administration de médicaments injectables
  • Administration topique de médicaments

  • Administration oculaire de médicaments

  • Administration pulmonaire de médicaments

  • Administration nasale de médicaments

  • Administration transmuqueuse de médicaments
  • Administration implantable de médicaments


Par application




  • Maladies infectieuses

  • Cancer

  • Maladies cardiovasculaires< /li>
  • Diabète

  • Maladies respiratoires

  • Troubles du système nerveux central

  • Maladies auto-immunes

  • Autres applications

  • < /ul>

    Par utilisateur final




    • Hôpitaux

    • Paramètres de soins à domicile

    • ASC/Cliniques

    • Autres utilisateurs finaux


    Par géographie




    • Amérique du Nord

      • États-Unis

      • Canada

      • Mexique


    • Europe

      • Allemagne

      • Royaume-Uni

      • France

      • Italie

      • < li>Espagne


    • Asie-Pacifique (APAC)

      • Chine

      • Inde

      • Japon

      • Corée du Sud

      • Australie



    • Moyen-Orient et Afrique (MEA)

      • Afrique du Sud

      • Arabie saoudite

      • EAU



    • Amérique du Sud et centrale (SCAM)

      • Brésil

      • Argentine



    Profils des entreprises




    • Pfizer Inc.

    • Bayer AG

    • Johnson & Johnson Services, Inc.

    • Novartis AG

    • 3M

    • Becton, Dickinson and Company

    • Sanofi

    • Merck KGaA

    • GlaxoSmithKline plc.

    • Antarès Pharma


Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What does pharmaceutical drug delivery mean?

Drug delivery systems are medical devices used to inject drugs or chemicals into the body. Some of the drug delivery systems available in the market include, transmucosal, oral, pulmonary, injectable, topical, nasal, implantable, and ocular among others. Drug delivery systems are the technologies primarily used for the controlled or targeted delivery of various therapeutic agents to treat various diseases or improve the health of the patients.

What are the driving and restraining factors for the pharmaceutical drug delivery market across the globe?

The growth of the market is attributed to some key driving factors such as growing prevalence of infectious and increasing r&d spending for drug delivery devices. However, high cost of drug delivery device development is likely to pose a negative impact on the market during the forecast years.

What is the regional analysis in terms of pharmaceutical drug delivery?

The North American region holds the largest market for the pharmaceutical drug delivery. The United States held the largest market for pharmaceutical drug delivery mean market and is expected to grow due to factors such as increasing incidence of cancer along with the growing need for diagnosing, demand for chronic disease medications from pharmaceutical companies, presence of key market players and extensive R&D conducted by various academic and research institutes.

The List of Companies - Pharmaceutical Drug Delivery Market

  1. Pfizer Inc.
  2. Bayer AG
  3. Johnson & Johnson Services, Inc.
  4. Novartis AG
  5. 3M
  6. Becton, Dickinson and Company
  7. Sanofi
  8. MERCK KGaA
  9. GlaxoSmithKline plc.
  10. Antares Pharma

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports